• Home
  • News
  • U.S. Track & Field Athlete Ridouane Harroufi Accepts Sanction for Second Anti-Doping Rule Violation

U.S. Track & Field Athlete Ridouane Harroufi Accepts Sanction for Second Anti-Doping Rule Violation

U.S. Track & Field Athlete Ridouane Harroufi Accepts Sanction for Second Anti-Doping Rule Violation

Press Release

28th September 2020

USADA announced today that Ridouane Harroufi, of Fort Collins, Colo., an athlete in the sport of track and field, has accepted an eight-year suspension for his second anti-doping rule violation. Harroufi’s first violation was announced in 2013, when he received a two-year suspension from World Athletics for his use of erythropoietin (EPO). Under the World Anti-Doping Code, an eight-year period of ineligibility is the maximum suspension allowed for a second violation.

“Harroufi has twice been found using powerful performance-enhancing drugs,” said USADA CEO Travis T. Tygart. “While this sanction will not restore the moment stolen from those he beat at the 15K USA Track & Field National Championship in March, it serves as a powerful reminder of the consequences of doping. This sanction and disqualification also show the importance of special analysis like Carbon Isotope Ratio testing to truly root out cheaters and that target testing with appropriate safety protocols during the COVID-19 pandemic is essential in preventing dopers from taking advantage of the situation and further harming clean athletes.”

Harroufi, 39, tested positive for an anabolic agent as the result of an in-competition drug test collected on March 7, 2020 at the USA Track & Field 15k Championships, as well as during an out-of-competition drug test collected on May 12, 2020. Both positive tests were considered a single violation because the second sample was collected before Harroufi was notified of the results of his first positive test.

USADA requested that his samples receive additional testing using a specialized analysis called Carbon Isotope Ratio (CIR) testing, which differentiates between anabolic-androgenic steroids (AAS) naturally produced by the body and prohibited anabolic agents of external origin. Anabolic agents have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors. Further, all urine and blood samples collected on athletes are examined for Athlete Biological Passport biomarker abnormalities that can be indicative of doping, therefore leading to follow-up testing and/or more specialized analyses.

All AAS are Non-Specified Substances in the class of Anabolic Agents and are prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the World Athletics Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency (WADA) Prohibited List.

Harroufi’s eight-year period of ineligibility began on June 12, 2020, the date his provisional suspension was imposed. In addition, Harroufi has been disqualified from all competitive results obtained on and subsequent to March 7, 2020, including his first-place finish at the 2020 USATF 15K National Championship, in addition to forfeiture of any medals, points and prizes.

Leave a comment

Please login to leave a comment.


Legal Advisors

Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.